typic
case
larg
confi
ned
adult
elderli
individu
sar
present
acut
respiratori
distress
syndrom
ard
characteris
presenc
diffus
alveolar
damag
dad
upon
autopsi
patholog
chang
lung
alveoli
like
follow
common
pathway
characteris
acut
phase
proteinrich
alveolar
fl
uid
infl
ux
alveolar
lumina
consequ
injuri
alveolar
wall
subsequ
pneumocyt
see
glossari
hyperplasia
occur
replac
loss
infect
pneumocyt
cover
denud
epitheli
basement
membran
result
restor
normal
alveolar
architectur
sever
alveolar
injuri
may
lead
fi
brosi
loss
alveolar
function
protract
case
sarscov
detect
respiratori
tract
also
faec
urin
patient
replic
viru
gastrointestin
tract
confi
rmed
electron
microscop
studi
biopsi
upper
lower
intestin
mucosa
patient
sar
faecal
transmiss
prove
import
least
one
major
commun
outbreak
hong
kong
patient
infect
within
day
develop
anim
model
sarscov
infect
human
utmost
import
elucid
pathogenesi
sar
develop
intervent
strategi
infect
wide
rang
anim
speci
suscept
experiment
infect
sarscov
includ
rodent
mice
hamster
carnivor
ferret
cat
nonhuman
primat
cynomolgu
rhesu
macaqu
common
marmoset
african
green
monkey
adult
mice
infect
vari
dose
sarscov
respiratori
tract
show
clinic
sign
diseas
although
viru
replic
respiratori
tissu
peak
earli
infect
viral
titr
lung
reach
rel
high
level
infect
accompani
mild
infl
ammatori
chang
respiratori
tract
hand
age
mice
well
hamster
ferret
show
sign
clinic
diseas
weight
loss
ruffl
ed
fur
albeit
case
absenc
typic
lung
lesion
seen
human
sar
contrast
sarscov
inocul
respiratori
tract
cynomolgu
macaqu
caus
infect
bronchial
epitheli
cell
pneumocyt
one
four
day
postinfect
follow
extens
pneumocyt
hyperplasia
lung
four
six
day
postinfect
moreov
multipl
foci
acut
dad
observ
characteris
fl
ood
alveoli
proteinrich
oedema
fl
uid
mix
variabl
number
neutrophil
rare
syncytia
figur
extens
loss
epithelium
alveolar
bronchiolar
wall
lesion
quit
similar
observ
human
acut
stage
sar
although
clinic
sign
respiratori
distress
gener
malais
observ
studi
initi
experi
studi
differ
laboratori
confi
rmed
nonhuman
primat
could
infect
experiment
sarscov
although
sever
perspect
section
expert
discuss
clinic
practic
public
health
implic
publish
articl
freeli
avail
onlin
differ
delin
viru
strain
age
microbiolog
state
genet
background
origin
anim
could
play
role
issu
plo
medicin
jame
lawler
jason
paraga
colleagu
provid
support
use
cynomolgu
macaqu
model
studi
pathogenesi
sar
test
intervent
strategi
show
infect
macaqu
molecularli
clone
sarscov
result
mildtomoder
symptomat
ill
indistinguish
ill
induc
wildtyp
sarscov
chest
radiograph
sever
infect
anim
show
unifoc
multifoc
pneumonia
peak
eight
ten
day
postinfect
author
point
result
reminisc
milder
syndrom
observ
younger
human
infect
sarscov
molecular
modifi
cation
clone
viru
may
allow
deciph
role
differ
viral
gene
product
pathogenesi
sar
import
result
present
studi
observ
one
group
anim
inocul
via
nasal
ocular
rout
exhibit
signifi
cant
faecal
shed
sarscov
thu
far
effort
evalu
effi
caci
sarscov
vaccin
larg
aim
protect
respiratori
tract
persist
threat
possibl
new
introduct
sarscov
relat
viru
human
popul
necessit
refi
nement
anim
model
elucid
pathogenesi
intervent
strategi
sar
although
none
current
anim
model
fulli
reproduc
featur
sar
import
aspect
sar
observ
experiment
infect
nonhuman
primat
model
alreadi
demonstr
protect
effect
preand
postexposur
use
pegyl
human
candid
sarscov
vaccin
convalesc
sera
sar
patient
unpublish
result
absenc
ongo
human
sarscov
infect
candid
sar
vaccin
may
approv
basi
anim
data
alon
prefer
two
differ
speci
two
anim
rule
order
approv
pathophysiolog
mechan
underli
sar
pathogenesi
prevent
effi
caci
vaccin
need
well
understood
present
studi
support
use
nonhuman
primat
sar
model
pathogenesi
studi
develop
intervent
strategi
infect
cynomolgu
macaqu
recombin
sarscov
contain
defi
ned
modifi
cation
may
allow
elucid
sar
pneumocyt
cell
respons
alveolar
ga
exchang
replic
suscept
larg
number
toxic
insult
pneumocyt
cell
respons
produc
secret
surfact
replic
alveoli
replac
damag
pneumocyt
